CAS No: 871038-72-1
Empirical formula: C20H20FKN6O5
Molecular weight: 482.51
Raltegravir is an antiretroviral Active Pharmaceutical Ingredient (API) that inhibits HIV integrase. It is clinically used to treat the HIV infection and decrease infection rates by preventing insertion of HIV-1 DNA into the host genome. Raltegravir is the first-in-class integrase inhibitor.
VIO Chemicals offers Raltegravir API manufactured using a non-infringing and competitive process with respect to the prior art in terms of raw material consumptions, atom and step economy. The process was designed, developed and optimized in-house for lean and scalable manufacturing, providing an additional advantage for high-volume products such as Raltegravir.
VIO Chemicals also offers advantageous and non-infringing crystalline form options, which enable early access to the European market.
Want to have regular news and product updates sent to your inbox?
Simply fill in your email address below and press subscribe.
You can easily unsubscribe at anytime and your email address will not be given to any third party.